vitamin-b-12 and Peripheral-Arterial-Disease

vitamin-b-12 has been researched along with Peripheral-Arterial-Disease* in 4 studies

Reviews

1 review(s) available for vitamin-b-12 and Peripheral-Arterial-Disease

ArticleYear
The role of nutrition and body composition in peripheral arterial disease.
    Nature reviews. Cardiology, 2012, Volume: 9, Issue:11

    Peripheral arterial disease (PAD) has not been as extensively investigated as other cardiovascular diseases. However, the available data suggest that nutrition-based treatment strategies have the potential to reduce the cost-economic burden of PAD substantially. Abdominal obesity is associated with PAD and prospective and cross-sectional studies have shown that a low dietary intake of folate and reduced synthesis of vitamin D are associated with an increased risk of PAD and severe walking impairment in patients who have the disease. However, dietary patterns that are associated with decreased cardiovascular risk might protect against PAD. A small number of clinical trials have provided evidence that increased intakes of niacin and insoluble fiber might be associated with decreased levels of LDL cholesterol and thrombogenic biomarkers, as well as increased serum levels of HDL cholesterol in patients with PAD. However, little evidence that antioxidants, vitamins B(6) and B(12), or essential fatty acid supplements improve clinical outcomes in these patients exists. Overall, data on the effects of nutrition, body composition, and nutritional supplementation on the risk, progression, and prognosis of PAD are scarce. Further research into these areas is required to allow the development of evidence-based nutritional guidelines for the prevention and treatment of the disease.

    Topics: Body Composition; Cardiovascular Diseases; Dietary Supplements; Disease Progression; Ethnicity; Folic Acid; Humans; Nutritional Status; Obesity, Abdominal; Peripheral Arterial Disease; Prognosis; Risk Factors; Vitamin B 12; Vitamin D

2012

Trials

2 trial(s) available for vitamin-b-12 and Peripheral-Arterial-Disease

ArticleYear
Vitamin B12 level in peripheral arterial disease.
    Journal of thrombosis and thrombolysis, 2013, Volume: 36, Issue:1

    Hyperhomocysteinemia is considered a risk factor for atherosclerosis. Methyltetrahydrofolate reductase (MTHFR) gene mutation and low level of plasma vitamin B12 and folate could take part in the etiology of peripheral arterial disease (PAD). We examined whether plasma vitamin B12 and folate levels and MTHFR-C677T polymorphism are associated with the risk of PAD. The study comprised 293 patients (107 females, 186 males, mean age of 66 ± SEM0.7 years) and 293 sex-matched control subjects (mean age of 62 ± SEM0.8 years). We also determined plasma lipid profile, hs-CRP, creatinine, vitamin B12, folate and total homocysteine (tHcy) for all patients and controls. Odds ratios were non-significant for different genotypes of MTHFR-C677T polymorphism. There was a significant lower level of vitamin B12 in PAD patients. 43 and 25 % of patient and control populations were in the lowest quartile of vitamin B12 (<188 pmol/L), respectively. Plasma level of vitamin B12 in the lowest quartile significantly increased tHcy level in PAD patients, and it was independent of plasma folate level. Low level of plasma vitamin B12 was independently associated with hyperhomocysteinemia in PAD patients. The prevalence of the MTHFR-C677T mutation was not significantly different in patients with PAD compared with controls.

    Topics: Aged; Amino Acid Substitution; Female; Homocysteine; Humans; Hyperhomocysteinemia; Lipids; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation, Missense; Peripheral Arterial Disease; Polymorphism, Genetic; Risk Factors; Vitamin B 12

2013
Do novel risk biomarkers reflect the severity of peripheral arterial disease?
    Angiology, 2011, Volume: 62, Issue:2

    The association between novel atherosclerotic risk biomarkers and severity of peripheral arterial disease (PAD) was assessed. Patients (n = 133) with PAD were recruited. Established risk biomarkers including low- and high-density cholesterol, triglycerides, and blood pressure were measured. Novel risk biomarkers including plasma C-reactive protein, von Willebrand factor (vWF), interleukin 6, red cell folate (RCF), vitamin B12, total homocysteine (tHcy), and Hcy genotypes were also determined. The severity of PAD was evaluated, using ankle-brachial pressure index (ABPI), brachial-knee, and brachial-ankle pulse wave velocity (bk- and ba-PWV). Plasma tHcy and systolic blood pressure had a positive independent correlation with bk-PWV (β = +0.56, P = .02 and β = +0.38, P < .001, respectively). Red cell folate had an independent inverse correlation with bk-PWV (β = -0.01, P = .01). Systolic blood pressure showed an independent positive correlation with ba-PWV only after adjustment for other risk biomarkers (β = +0.1, P = .04). Novel markers, plasma tHcy, and RCF levels correlated with the severity of PAD.

    Topics: Aged; Aged, 80 and over; Ankle Brachial Index; Biomarkers; Blood Coagulation Factors; Blood Flow Velocity; C-Reactive Protein; Female; Folic Acid; Homocysteine; Humans; Inflammation Mediators; Lipids; Male; Middle Aged; Peripheral Arterial Disease; Predictive Value of Tests; Severity of Illness Index; Vitamin B 12

2011

Other Studies

1 other study(ies) available for vitamin-b-12 and Peripheral-Arterial-Disease

ArticleYear
Homocysteine is a determinant of ApoA-I and both are associated with ankle brachial index, in an ambulatory elderly population.
    Atherosclerosis, 2011, Volume: 214, Issue:2

    The ankle brachial index (ABI) is an indicator of lower extremity peripheral arterial disease (PAD) and a predictor of atherothrombosis. ApoA-I and HDL are associated with PAD, in humans. Homocysteine influences the liver expression of ApoA-I and decreases its blood level and HDL in genetic mice models. We aimed therefore to evaluate whether homocysteine and its nutritional determinants, folate and vitamin B12 are associated with ABI by influencing HDL metabolism, in an ambulatory elderly population.. 667 elderly volunteers from rural Sicily were assessed for ABI, homocysteine and its determinants, lipid markers and other predictors of PAD. HDL size was assessed in 15 sera in upper and lower quartiles of Hcy distribution.. In multivariate analysis, ApoA-I and homocysteine were two predictors of ABI (β-coefficient = 2.86, P<0.004 and β-coefficient = -3.41, P<0.001, respectively). Homocysteine correlated negatively with ApoA-I (R = -0.147, P<0.001) and with HDL-Cholesterol (R = -0.113, P = 0.003). The associations of homocysteine, vitamin B12 and methylmalonic acid with ApoA-I and HDL2a particles and that of homocysteine with increased small size HDL3c suggested mechanisms related with impaired synthesis of ApoA-I and HDL and abnormal maturation of HDL particles.. The influence of homocysteine on ApoA-I and HDL metabolism provides new insights on its role on vascular diseases, at a cross-point between atherosclerosis and atherothrombosis.

    Topics: Age Factors; Aged; Aged, 80 and over; Ankle Brachial Index; Apolipoprotein A-I; Biomarkers; Cholesterol, HDL; Female; Folic Acid; Homocysteine; Humans; Independent Living; Male; Methylmalonic Acid; Middle Aged; Particle Size; Peripheral Arterial Disease; Regression Analysis; Risk Assessment; Risk Factors; Sicily; Vitamin B 12; Walking

2011